Spero Therapeutics Inc (NASDAQ:SPRO) price closed higher on current market day and jumping 3.26% above its previous close.
A look at the daily price movement shows that the last close reads $2.76. Taking into account the 52-week price action we note that the stock hit a 52-week high of $2.95 and 52-week low of $0.51. The stock added 359.68% on its value in the past month.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 1 analysts have assigned SPRO a recommendation rating as follows: 0 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the Spero Therapeutics Inc (SPRO) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Buy, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that SPRO’s price is at present 75.58% off the SMA20 and 172.88% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 81.04, with weekly volatility standing at 6.23%. The indicator jumps to 28.03% when calculated based on the past 30 days. Spero Therapeutics Inc (NASDAQ:SPRO)’s beta value is holding at 1.31, while the average true range (ATR) indicator is currently reading 0.25.
Current records show that the company has 55.90M in outstanding shares. The insiders’ percentage holdings are 33.16% of outstanding shares while the percentage share held by institutions stands at 20.66%. But the 176.70% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
